Real-time enrollment status for this relapsed hematologic malignancy clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 11:59 PM UTC
| NCT Number | NCT05713214 |
| Recruiting Status | Recruiting |
| Condition | Relapsed Hematologic Malignancy |
| Phase | Clinical Trial |
| Target Enrollment | 500 participants |
| Active Locations | 1 sites in the US |
| Sponsor | St. Jude Children's Research Hospital |
| Last Updated on CT.gov | June 17, 2026 (4 weeks ago) |
As of July 16, 2026: Clinical trial NCT05713214 is currently recruiting participants. This clinical trial study for relapsed hematologic malignancy is actively seeking new participants at 1 location across the United States. The study is sponsored by St. Jude Children's Research Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05713214 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05713214 was last updated 4 weeks ago (June 17, 2026). HelloStudys verifies this status automatically.